Eden and Shed both specialize in GLP-1 weight loss treatment but take different approaches. Eden offers a Price Lock Guarantee and serves ED/hair loss too, while Shed focuses exclusively on weight loss with a 10% weight loss money-back guarantee and four medication formats. We compared pricing, guarantees, and patient outcomes.
Platform Overview
Eden is a GLP-1 specialist telehealth platform operating since 2021, positioning itself as a premium weight loss solution for patients who want complete coaching alongside their medication. Eden charges $247-$397 per month and emphasizes a high-touch clinical model with dedicated dietitians, behavioral coaches, and physician oversight. The platform has built a reputation among patients seeking structured support, and its care team model draws on evidence that combined lifestyle and pharmacological intervention produces superior outcomes compared to medication alone, as documented in
clinical trials published by NEJM.
Shed is a GLP-1 weight loss specialist founded with a singular focus on semaglutide and tirzepatide-based programs, offering plans from $199-$499 per month. What distinguishes Shed from most competitors is its 10% body weight loss guarantee, a commitment backed by its clinical protocols and dedicated weight loss coaching. Shed's approach aligns with FDA-approved GLP-1 treatment frameworks and emphasizes sustained results over quick fixes, making it a strong contender for patients who want accountability with their GLP-1 treatment.
Pricing Comparison
Eden's pricing sits at $247-$397 per month depending on the plan tier and medication included. The higher end of Eden's pricing reflects its premium coaching model, which bundles dietitian access and behavioral support into the program cost. While this represents strong value for patients who actively engage with coaching resources, patients who primarily need medication management without intensive coaching may find they are paying for services they underutilize. Eden does not publicly advertise an outcome guarantee, which means patients absorb the financial risk if results are slower than expected.
Shed's pricing of $199-$499 per month is competitive across the GLP-1 telehealth market, and the platform's 10% weight loss guarantee is a meaningful differentiator from a value standpoint. Patients who do not achieve the guaranteed threshold may be eligible for program adjustments or refund options, reducing downside financial risk. The
CDC notes that even a 5-10% reduction in body weight produces significant health improvements, making Shed's guarantee clinically meaningful. For budget-conscious patients, Shed's entry-level pricing is lower than Eden's floor.
Medication Options and Quality
Eden offers both semaglutide and tirzepatide through licensed compounding pharmacies, ensuring patients have access to the most clinically validated GLP-1 medications available. The platform works with FDA-registered compounding facilities, and its prescribing physicians titrate dosing based on individual patient response. Clinical data shows tirzepatide (the active ingredient in Zepbound/Mounjaro) produces average weight loss of 20-22% of body weight in trials, as reported by
NEJM research on tirzepatide efficacy. Eden's pharmacy partnerships are a key quality marker that patients should verify during their intake process.
Shed similarly provides access to both semaglutide and tirzepatide, prescribed by licensed medical providers following a thorough intake evaluation. The platform's medication protocols follow established GLP-1 dosing guidelines and include regular check-ins to assess tolerability and adjust doses as needed. Shed's clinical team monitors for common side effects including nausea and gastrointestinal discomfort, which affect roughly 30-40% of GLP-1 users according to FDA medication labeling. Both semaglutide and tirzepatide options at Shed are sourced through compliant pharmacy channels.
Medical Team and Support
Eden's clinical model is one of its strongest selling points. The platform employs a multi-disciplinary team including physicians, nurse practitioners, registered dietitians, and behavioral health coaches. Patients are assigned to a care team rather than seeing rotating providers, which promotes continuity and stronger therapeutic relationships. Research published in JAMA confirms that ongoing behavioral support significantly improves weight loss maintenance beyond the initial treatment period. Eden's dietitian access is particularly valuable for patients managing co-morbidities like type 2 diabetes or hypertension alongside their weight loss goals.
Shed provides dedicated weight loss coaching as a core feature of its program, distinguishing it from bare-bones telehealth platforms that simply prescribe medication with minimal follow-up. Coaches work with patients on behavioral strategies, goal setting, and adherence support throughout the program. Medical oversight is provided by licensed physicians and nurse practitioners who monitor patient progress and adjust prescriptions as needed. The
American Association of Clinical Endocrinology guidelines recommend combined pharmacological and behavioral treatment for optimal obesity management, a model Shed's program is designed around.
Weight Loss Approach and Programs
Eden takes an integrative approach to weight loss that combines GLP-1 pharmacotherapy with structured lifestyle coaching. The platform's programs include nutritional guidance, physical activity recommendations, and behavioral modification techniques drawn from cognitive behavioral therapy principles. Eden's program design reflects the consensus position of major obesity medicine organizations that medication alone produces inferior long-term outcomes compared to combined treatment. Patients on Eden's premium tiers receive the most intensive support, including regular check-ins with their assigned dietitian and coach. This model is particularly effective for patients with a history of weight cycling or prior unsuccessful diet attempts.
Shed's weight loss approach centers on its 10% body weight guarantee - a bold commitment that shapes every element of the program design. The platform's protocols are calibrated to achieve clinically meaningful weight loss within the program timeline, with coaching support focused on maximizing patient adherence to both medication and lifestyle modifications.
Research published in Obesity journal demonstrates that GLP-1 medications combined with structured support consistently outperform medication-only protocols. Shed's guarantee creates strong incentive alignment between the platform and the patient.
User Experience and Satisfaction
Eden patients generally report high satisfaction with the platform's coaching quality and the attentiveness of their assigned care team. The onboarding process is thorough, including a detailed health history intake and goal-setting session with a coach before medication is prescribed. The platform's app and patient portal receive positive reviews for ease of use and communication features. Some patients note that Eden's higher price point can be a barrier, particularly for those on long-term weight maintenance programs where the cost accumulates significantly over time. Eden's premium positioning means it attracts patients who are highly motivated and willing to invest in a complete program.
Shed users frequently cite the weight loss guarantee as a major factor in their decision to choose the platform. The guarantee reduces anxiety about whether the investment will produce results, and patients report that the coaching team is responsive and proactive about checking in on progress. The platform's interface is straightforward and access to the care team is described as readily available. As with most GLP-1 programs, patients may experience an adjustment period with side effects in the first 4-8 weeks, and Shed's coaching team plays an active role in helping patients manage this phase. The
NIH notes that adherence support is critical during the early medication phase.
How We Tested Eden vs Shed
Our Comparison Methodology
This comparison is based on complete analysis supplemented by peer-reviewed research on weight loss treatment.
Clinical Evidence: Weight loss treatment recommendations reference FDA-approved GLP-1 medication information (FDA Wegovy Label), obesity treatment guidelines from the American Association of Clinical Endocrinology, and clinical efficacy data from The New England Journal of Medicine.
Research Foundation: We analyzed peer-reviewed studies including GLP-1 medication efficacy from Obesity and behavioral support impact from JAMA.
Pricing Analysis: All pricing reflects published rates as of March 2026, verified through official platform websites.
Service Verification: Platform capabilities, provider credentials, and service quality were evaluated through detailed review of service offerings.
We maintain independence from both platforms and receive no compensation. Our goal is to provide evidence-based comparison to help you make informed weight loss treatment decisions.
Final Verdict: Eden vs Shed
Choose Eden if: You want a premium, multi-disciplinary weight loss program with dedicated dietitian access and behavioral coaching. Eden is best suited for patients with complex health histories, co-morbidities, or a history of weight cycling who benefit from intensive clinical support alongside their GLP-1 medication.
Choose Shed if: You want a GLP-1 program backed by a concrete 10% weight loss guarantee and are looking for strong coaching support at a more accessible price point. Shed is ideal for patients who are motivated and want outcome accountability built into their program contract.
Bottom line: Both Eden and Shed are credible GLP-1 weight loss platforms that go beyond simple prescription services. Eden wins on coaching depth and clinical team breadth, while Shed wins on value assurance through its weight loss guarantee. Most patients will achieve strong results with either platform as long as they remain adherent to the program - the deciding factor is whether you prioritize complete clinical support (Eden) or guaranteed outcome accountability (Shed).
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
